Surge

SurgeCare – Transforming Immune Insights into Clinical Impact

Paris, France · Founded 2021 · $10.8M raised

Headquarters
Paris
Employees
11–50
Founded
2021
Business Model
B2B
Website
surge.care
Total Funding
$10.8M
Last Round
$8.3M Series BMar 2024
Rounds
2

About

SurgeCare is a Paris-based medtech company, born from ten years of Stanford University immunology research, that decrypts each patient's hidden immune signature to advance precision medicine. The platform applies single-cell omics technologies and machine learning to reveal early immune signatures that predict medical outcomes including surgical complications, trauma responses, and implant rejection. Founded by Stanford physician-scientist Brice Gaudilliere and biomedical informatics expert Julien Hedou, Surge delivers actionable clinical insights that enable personalized perioperative care and improved patient outcomes.

Summary

Surge is a Medtech company based in Paris, France, founded in 2021. It has raised $10.8M in total across 2 rounds, most recently a $8.3M Series B round in Mar 2024. Investors include Eurazeo, Hcvc and Kima Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMar 2024
$8.3M

Sign up to see all 2 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Surge on Indexed.vc
<a href="https://indexed.vc/companies/surge"><img src="https://indexed.vc/api/badge/company/surge" alt="Surge on Indexed.vc" width="260" height="76" /></a>